SCHEMBL9018385

SCHEMBL9018385

CC(C)(C)C(=O)c1ccc(C=CC(=O)NCc2cc(C(C)(C)C)c(O)c(C(C)(C)C)c2)cc1

nearest known ligand 0.47

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
▸ MMP1 P03956 3/20 0.47
▸ MMP2 P08253 3/20 0.47
▸ MMP9 P14780 3/20 0.47
▸ TNFRSF1A P19438 1/20 0.46
▸ KDM4E B2RXH2 1/20 0.44
▸ MAOA P21397 5/20 0.44
▸ MAOB P27338 5/20 0.44
▸ ACHE P22303 4/20 0.43
▸ BCHE P06276 1/20 0.43
▸ HDAC3 O15379 1/20 0.42
▸ HDAC1 Q13547 1/20 0.42
▸ HDAC2 Q92769 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9018291 0.89 MMP1 (0.51) MMP1MMP2MMP9TNFRSF1AKDM4E
SCHEMBL9018395 0.88 MMP1 (0.61) MMP1MMP2MMP9TNFRSF1AKDM4E
SCHEMBL9567391 0.86 SMN1; SMN2 (0.58) MMP1MMP2MMP9MAOAMAOB
SCHEMBL9018321 0.86 MMP1 (0.49) MMP1MMP2MMP9TNFRSF1AKDM4E
SCHEMBL9018276 0.86 MMP1 (0.49) MMP1MMP2MMP9TNFRSF1AKDM4E
SCHEMBL11304619 0.85 MMP1 (0.63) MMP1MMP2MMP9TNFRSF1AMAOA
SCHEMBL11304615 0.85 MMP1 (0.63) MMP1MMP2MMP9TNFRSF1AMAOA
SCHEMBL9018426 0.84 KDM4E (0.44) MMP1MMP2MMP9TNFRSF1AKDM4E
SCHEMBL9018405 0.84 HDAC3 (0.54) MMP1MMP2MMP9TNFRSF1AKDM4E
SCHEMBL9018355 0.83 MMP1 (0.65) MMP1MMP2MMP9MAOAACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0600949-B1 NEW 3,5-DI-TERT.BUTYL-4-HYDROXYPHENYL DERIVATIVES, METHODS OF PREPARING THEM AND DRUGS CONTAINING THEM BOEHRINGER MANNHEIM GMBH (DE) 1996-01-10 — — EP disclosed
EP-0527458-A1 New 3,5-di-tert.-butyl-4-hydroxyphenyl derivatives, process for their preparation and pharmaceutical compounds Roche Diagnostics GmbH (DE) 1993-02-17 — — EP disclosed
Send feedback